FDA Oct. 11 Grand Rounds Presents: What you need to know about the science behind a nicotine tobacco product standard

The October 11 FDA Grand Rounds Presents:   The Science to Inform a Tobacco Product Standard for the Level of Nicotine in Combusted Cigarettes

Thursday, October 11, 2018 12:00 p.m. - 1:00 p.m. EST   Register here for webcast (public attendees and FDA staff)   Presented by    Lynn Hull, PhD Lead Pharmacologist FDA’s Center for Tobacco Products   About the Presentation   Dr. Hull will give an overview of the systematic literature review done by FDA’s Center for Tobacco Products on the likely effects of reducing nicotine in combusted tobacco -- and on consumer knowledge, attitudes, perceptions, beliefs, and planned behavior on reduced nicotine tobacco products. Use of combusted tobacco products like cigarettes, kreteks, bidis, cigarette tobacco, roll-your-own tobacco, cigars, pipe tobacco, and water pipe tobacco causes a heavy burden of death and disease each year. These negative health effects are ultimately the result of users’ addiction to the nicotine in tobacco products, which in turn results in their repeated use. This continuously exposes users and non-users (via second- or third-hand smoke) to toxicants in the smoke.  FDA has issued an Advanced Notice of Proposed Rulemaking for a product standard to set a maximum nicotine level in cigarettes. The Agency continues to assess the best available science to determine a level at which these products would be minimally addictive and, therefore, appropriate for protecting the public health